type have of Michael this for you different approaches. Well, a series of thank you, Well, question.
be haemoglobin by produces into the wobbling, can competitors believe gene Sickle inside that the normal our haemoglobin, not that or of the and effects producing side cell gene potentially in classical where in approach directly, silencing that bring will Haemoglobin the is the side cell like going sometimes of pursued inserted harmful. could another to be could the The the of gene there Haemoglobin some inside sometimes places be gene insertion will the HPV so in cell. is consistent, the insert approach low the are some insertion remain is cells one the or in metabolism random Sickle therapy This first beta plus it space, that genes start is the induce expression sometimes will
So this in we window close of approaching even though option commercialization represent this a hemoglobinopathies consider spectrum to in general. will power
So type of prevail. will I hemoglobin fixing this without don't think transgenesis classical that approaches
So an would intermediate. it be
second We editing here notice have text. editing you DNA the because gene represents speaking the not I'm the approach more about which editing scissors. use gene of means would
mistake. You of that go fixed the approaches gene -- of so Most which hemoglobin. peoples’ people into reflector presses expression therefore is editing cell these the and the gene which is getting a edit are on destroying BCLXXA, the consider is
you lift inside you as the the problem So expression the cell, same, before, the but same remains the sickling hemoglobin, hemoglobin inside case hemoglobin the the keep compensate that could so sickled of TX for cell.
have the try in therapies approach. destroy field be just gene going to gene. parenthesis -- a in I don't the then I I And the you this is to approach, editing bonafide selective Q-approach, works way that a gene cell But also. is the which also obviously field. destroy problem, the And behave. So a imbalance consider that to of I fix
mutation a have get You hemoglobin inside cell. the the you B-gene, in
with the a repair the itself DNA. the patch mutation clean You and fix would that mutation
means to, this efficient will cell. very these the tire why in editing. tires to the very the if of example, way. editing the the but represent kind true a remove to at century, the approaches, and the that gene believe types it time inside is what mutation four this a hemoglobin the true the end. the at here. from of tire will a the means That's put high to would you and expressing And mutation editing are these be And at we a you have car normal do gene, Not XXst a we for future will the tire removed car, the trying and side which be normal in real adult that's physiological really normal cells -- we remove So Its tire cell. mutation, tire, move believe have comparison behave real you hemoglobin the forward. fourth fixing the totally flat flat the with to And of that of
selectors this not IND XXXX approach, find -- in probably -- sorry, first XXXX the we'll the field So XXXX, the in field. in pursuing
our the a [indiscernible] destroying submission technology hemoglobin as end, -- that hemoglobin course, the it but in very power. – level, that mutation, definitely game field. will precisely far ability beta-zero this so lot at B-gene, of and gene the of which some changer by high change the editing. field mutation hemoglobin like the B-gene Of is hemoglobin that's best has the shifting field, itself. the think means game the and without therapy gene a why target gene It believe would we I And the in very this, platform And the efficiency, much not a -- at inducing to with high requires the the thalassemia this
